Development Level

Tbio 175 | 10,625
Tchem 99 | 1,890
Tclin 50 | 602
Tdark 6 | 7,003

Collection

Eligible Kinase Proteins 3 | 134
Eligible Ion Channel Proteins 1 | 117

IMPC Term

preweaning lethality, complete... 16 | 633
decreased body weight 9 | 174
decreased total body fat amoun... 8 | 186
abnormal bone structure 6 | 131
abnormal embryo size 6 | 112
decreased bone mineral content 6 | 157
decreased circulating choleste... 6 | 85
decreased lean body mass 6 | 195
embryonic lethality prior to t... 6 | 187
decreased circulating HDL chol... 5 | 77
decreased lumbar vertebrae num... 5 | 62
abnormal retina morphology 4 | 100
decreased circulating LDL chol... 4 | 37
decreased circulating alanine ... 4 | 53
decreased circulating triglyce... 4 | 83
enlarged heart 4 | 111
increased mean corpuscular hem... 4 | 93
abnormal behavior 3 | 226
abnormal bone mineralization 3 | 55
abnormal retinal pigmentation 3 | 61
cataract 3 | 26
decreased body length 3 | 108
decreased fasted circulating g... 3 | 49
decreased grip strength 3 | 123
decreased kidney weight 3 | 7
increased bone mineral content 3 | 92
increased circulating alkaline... 3 | 119
increased grip strength 3 | 83
male infertility 3 | 62
thrombocytopenia 3 | 46
abnormal coat/hair pigmentatio... 2 | 54
abnormal cornea morphology 2 | 24
abnormal forebrain development 2 | 18
abnormal head morphology 2 | 10
abnormal hindbrain development 2 | 24
abnormal lens morphology 2 | 73
abnormal midbrain development 2 | 22
abnormal neural tube closure 2 | 37
abnormal seminal vesicle morph... 2 | 47
decreased blood urea nitrogen ... 2 | 31
decreased caudal vertebrae num... 2 | 49
decreased circulating bilirubi... 2 | 14
decreased circulating creatini... 2 | 31
decreased circulating glucose ... 2 | 121
decreased circulating insulin ... 2 | 75
decreased circulating potassiu... 2 | 17
decreased circulating serum al... 2 | 79
decreased circulating sodium l... 2 | 18
decreased circulating total pr... 2 | 41
decreased coping response 2 | 5
decreased heart weight 2 | 44
decreased lactate dehydrogenas... 2 | 14
decreased neutrophil cell numb... 2 | 37
decreased rib number 2 | 59
decreased spleen weight 2 | 13
decreased thoracic vertebrae n... 2 | 7
dilated heart left ventricle 2 | 10
impaired pupillary reflex 2 | 14
impaired righting response 2 | 19
increased blood urea nitrogen ... 2 | 44
increased body length 2 | 20
increased circulating HDL chol... 2 | 63
increased circulating LDL chol... 2 | 15
increased circulating iron lev... 2 | 25
increased circulating phosphat... 2 | 24
increased circulating potassiu... 2 | 31
increased hemoglobin content 2 | 45
increased lean body mass 2 | 107
increased sacral vertebrae num... 2 | 62
increased startle reflex 2 | 38
prenatal lethality prior to he... 2 | 64
preweaning lethality, incomple... 2 | 260
short tibia 2 | 82
abnormal body wall morphology 1 | 7
abnormal gait 1 | 51
abnormal respiratory quotient 1 | 9
abnormal rib morphology 1 | 28
abnormal startle reflex 1 | 14
absent pinna reflex 1 | 21
corneal opacity 1 | 25
decreased NK cell number 1 | 16
decreased bone mineral density 1 | 126
decreased circulating calcium ... 1 | 33
decreased circulating chloride... 1 | 32
decreased effector memory CD8-... 1 | 24
decreased eosinophil cell numb... 1 | 41
decreased exploration in new e... 1 | 9
decreased total retina thickne... 1 | 20
female infertility 1 | 34
increased bone mineral density 1 | 52
increased circulating choleste... 1 | 53
increased mean corpuscular vol... 1 | 91
increased mean platelet volume 1 | 19
limb grasping 1 | 35
persistence of hyaloid vascula... 1 | 22
prenatal lethality 1 | 16
stereotypic behavior 1 | 3
tremors 1 | 34
trunk curl 1 | 15
vertebral fusion 1 | 23

Disease

ovarian cancer 195 | 8,492
osteosarcoma 184 | 7,933
glioblastoma 152 | 5,572
Cancer 142 | 2,346
psoriasis 138 | 6,685
medulloblastoma, large-cell 134 | 6,234
lung cancer 126 | 4,473
atypical teratoid / rhabdoid tumor 105 | 4,369
pilocytic astrocytoma 89 | 3,086
Breast cancer 87 | 3,099
invasive ductal carcinoma 84 | 2,950
Carcinoma 82 | 2,147
intraductal papillary-mucinous neoplasm (IPMN) 80 | 3,289
malignant mesothelioma 79 | 3,163
oligodendroglioma 76 | 2,849
pediatric high grade glioma 76 | 2,712
ependymoma 75 | 2,514
lung adenocarcinoma 70 | 2,714
lung carcinoma 69 | 2,844
subependymal giant cell astrocytoma 69 | 2,287
interstitial cystitis 68 | 2,299
non-small cell lung cancer 67 | 2,798
intraductal papillary-mucinous adenoma (IPMA) 64 | 2,956
primitive neuroectodermal tumor 64 | 3,031
intraductal papillary-mucinous carcinoma (IPMC) 62 | 2,988
astrocytic glioma 61 | 2,241
pancreatic cancer 61 | 2,300
ulcerative colitis 60 | 2,087
Multiple myeloma 56 | 1,328
diabetes mellitus 52 | 1,663
cystic fibrosis 51 | 1,670
tuberculosis 49 | 1,563
pituitary cancer 48 | 1,972
group 4 medulloblastoma 47 | 1,875
medulloblastoma 45 | 1,524
group 3 medulloblastoma 44 | 2,254
Pick disease 42 | 1,893
astrocytoma 42 | 1,493
ductal carcinoma in situ 41 | 1,745
Rheumatoid Arthritis 39 | 1,171
pancreatic ductal adenocarcinoma liver metastasis 39 | 1,795
breast carcinoma 38 | 1,614
colon cancer 37 | 1,475
adult high grade glioma 36 | 2,148
Mammary Neoplasms 34 | 410
primary pancreatic ductal adenocarcinoma 34 | 1,271
Waldenstrons macroglobulinemia 32 | 765
adrenocortical carcinoma 30 | 1,427
juvenile dermatomyositis 30 | 1,189
posterior fossa group A ependymoma 29 | 1,511
Schizophrenia 28 | 503
cutaneous lupus erythematosus 27 | 1,056
Prostatic Neoplasms 26 | 471
dermatomyositis 26 | 967
posterior fossa group B ependymoma 26 | 1,530
Intellectual disability 25 | 573
non-small cell lung carcinoma 25 | 413
gastric carcinoma 24 | 832
Parkinson's disease 23 | 364
Renal Cell Carcinoma 23 | 199
esophageal adenocarcinoma 23 | 737
spina bifida 23 | 1,064
Alzheimer's disease 22 | 644
Liver carcinoma 21 | 217
Obesity 21 | 616
Vascular disease 21 | 281
atypical teratoid/rhabdoid tumor 21 | 1,095
tuberculosis and treatment for 6 months 21 | 686
Atherosclerosis 20 | 275
Autistic Disorder 20 | 320
HIV Infections 20 | 100
Heart disease 20 | 279
Kidney disease 20 | 397
Lung Neoplasms 20 | 171
Stomach Neoplasms 20 | 282
non primary Sjogren syndrome sicca 20 | 840
pancreatic carcinoma 19 | 567
sonic hedgehog group medulloblastoma 19 | 1,482
primary Sjogren syndrome 18 | 789
Hypertension 17 | 293
Melanoma 17 | 261
Myocardial Ischemia 17 | 169
Neoplasm Invasiveness 17 | 127
acute quadriplegic myopathy 17 | 1,157
hepatocellular carcinoma 17 | 550
mucosa-associated lymphoid tissue lymphoma 17 | 480
Asthma 16 | 349
Atopic dermatitis 16 | 944
Down syndrome 16 | 548
Osteoporosis 16 | 259
Polycystic Ovary Syndrome 16 | 335
acute myeloid leukemia 16 | 785
autosomal dominant Emery-Dreifuss muscular dystrophy 16 | 499
fibroadenoma 16 | 557
nasopharyngeal carcinoma 16 | 1,056
Animal Mammary Neoplasms 15 | 136
IGA Glomerulonephritis 15 | 454
Mammary Neoplasms, Experimental 15 | 150
Crohn's disease 14 | 304
gastric cancer 14 | 436

Tissue

Endocrine System 330 | 18,512
Female tissues 330 | 18,647
Nervous System 330 | 18,561
Digestive Tract 329 | 18,473
Urinary Tract 329 | 18,444
Liver and Pancreas 328 | 18,136
Blood and immune system 327 | 17,995
Cardiovascular System 326 | 17,958
Skin and soft tissues 326 | 18,115
Male tissues 325 | 17,969
Respiratory system 321 | 17,484

Target Family

Non-IDG 165 | 11,969
Enzyme 87 | 4,146
Kinase 69 | 634
Ion Channel 9 | 341

Reactome Pathway

Signaling by VEGF 330 | 330
Signal Transduction 2,516 | 2,516
Immune System 2,184 | 2,184
Metabolism 2,132 | 2,132
Gene Expression 1,755 | 1,755
Metabolism of proteins 1,545 | 1,545
Innate Immune System 1,376 | 1,376
Signaling by GPCR 1,330 | 1,330
Developmental Biology 1,029 | 1,029
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,005 | 1,005
Adaptive Immune System 939 | 939
Disease 856 | 856
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 804 | 804
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 669 | 669
Membrane Trafficking 608 | 608
Cell Cycle 573 | 573
Axon guidance 542 | 542
Neutrophil degranulation 542 | 542
Signaling by Interleukins 501 | 501
Cell Cycle, Mitotic 471 | 471
Signalling by NGF 468 | 468
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 436 | 436
Class I MHC mediated antigen p... 431 | 431
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 424 | 424
Cellular responses to stress 416 | 416
DAP12 interactions 410 | 410
Infectious disease 392 | 392
NGF signalling via TRKA from t... 379 | 379
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 368 | 368
Diseases of signal transductio... 360 | 360
Signaling by EGFR 356 | 356
Transcriptional Regulation by ... 356 | 356
Metabolism of amino acids and ... 354 | 354
DAP12 signaling 347 | 347
Downstream signal transduction 344 | 344
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by SCF-KIT 328 | 328
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 322 | 322
FCERI mediated MAPK activation 317 | 317
Signaling by Insulin receptor 313 | 313
Antigen processing: Ubiquitina... 302 | 302
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 291 | 291
Signaling by Wnt 291 | 291
IGF1R signaling cascade 290 | 290
IRS-related events triggered b... 290 | 290
Insulin receptor signalling ca... 289 | 289
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 286 | 286
MAPK family signaling cascades 284 | 284
Signaling by the B Cell Recept... 283 | 283
Asparagine N-linked glycosylat... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 278 | 278
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 269 | 269
M Phase 267 | 267
Interleukin-3, 5 and GM-CSF si... 263 | 263
RET signaling 262 | 262
Signalling to ERKs 255 | 255
Interleukin-2 signaling 254 | 254
Immunoregulatory interactions ... 252 | 252
VEGFR2 mediated cell prolifera... 250 | 250
RHO GTPase Effectors 249 | 249
Signalling to RAS 248 | 248
Interleukin receptor SHC signa... 247 | 247
G alpha (i) signalling events 245 | 245
Signaling by Leptin 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Prolonged ERK activation event... 244 | 244
MAPK1/MAPK3 signaling 243 | 243
Frs2-mediated activation 242 | 242
HIV Infection 242 | 242
ARMS-mediated activation 241 | 241
Signalling to p38 via RIT and ... 241 | 241
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 237 | 237
RAF/MAP kinase cascade 237 | 237
SHC1 events in EGFR signaling 237 | 237
SOS-mediated signalling 237 | 237
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Ub-specific processing proteas... 203 | 203

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
cAMP-dependent protein kinase catalytic subunit alpha PRKACA Tchem Kinase -1.02404 9.59 274
Protein BRICK1 BRK1 Tbio Non-IDG -1.42109 29.2 53
Neurturin NRTN Tbio Non-IDG -2.19264 157.5 257
Talin-1 TLN1 Tbio Non-IDG -1.88948 80.4 340
Rap guanine nucleotide exchange factor 2 RAPGEF2 Tbio Non-IDG -1.34433 25.0 58
Insulin receptor substrate 2 IRS2 Tbio Non-IDG -2.62322 398.1 207
Protein kinase C beta type PRKCB Tchem Kinase -1.97915 83.5 530
Ragulator complex protein LAMTOR2 LAMTOR2 Tbio Non-IDG -0.93716 9.40 71
Fibroblast growth factor receptor substrate 2 FRS2 Tbio Non-IDG -2.33263 203.3 303
Ras-GEF domain-containing family member 1A RASGEF1A Tdark Non-IDG -0.56596 3.21 41